Search Medical Condition
Please enter condition
Please choose location

COPD (Chronic Obstructive Pulmonary Disease) Clinical Trials

A listing of COPD (Chronic Obstructive Pulmonary Disease) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (238) clinical trials

Summary: A clinical research study for an investigational medication for Chronic Obstructive Pulmonary Disease (COPD).

Phase

If you are a current or former smoker and experience symptoms from COPD (also known as emphysema or chronic bronchitis) such as wheezing, coughing, breathlessness or chest tightness, you may qualify for one of our paid research studies.

Phase

ActivMed Practices & Research of Portsmouth NH is conducting a research study on COPD.

Phase N/A

Nearly 15 million Americans suffer from chronic obstructive pulmonary disease (COPD), which includes emphysema and chronic bronchitis. COPD makes it hard to breathe, and can also cause wheezing, coughing, and chest tightness. Right now, doctors at Columbus Regional Research Institute are accepting participants for a new COPD research study. The ...

Phase N/A

This research study is testing whether a new investigational drug could help patients with COPD (chronic obstructive pulmonary disease) control symptoms and reduce exacerbations (flare-ups).

Phase

You are being asked to participate in this research study because you have moderate to very severe Chronic Obstructive Pulmonary Disease or COPD and a history of COPD exacerbations. The purpose of this study is to assess the effects of BGF MDI, GFF MDI and BFF MDI on the rate ...

Phase

This is a research study to test investigational drugs for which Pearl Therapeutics plans to seek marketing approval from the U.S. Food and Drug Administration (FDA) and Regulatory Authorities in other countries. The purpose of this study is to: Evaluate the effect of BGF MDI, GFF MDI, and BFF MDI ...

Phase

We will examine whether or not lebrikizumab improves lung function in people with COPD. We also hope to learn whether lebrikizumab reduces the number of COPD exacerbations and improves symptoms in people who do not have good control of their COPD despite being treated with a long-acting bronchodilator and an ...

Phase

The purpose of this study is to measure the effectiveness and safety of TD-4208, a drug being developed for people with moderate to very severe COPD, compared to a drug called tiotropium.

Phase N/A

This is a research study to test investigational drugs for which Pearl Therapeutics plans to seek marketing approval from the U.S. Food and Drug Administration (FDA) and Regulatory Authorities in other countries. The purpose of this study is to: Assess the effects of BGF MDI, GFF MDI, BFF MDI, and ...

Phase